Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Accelerate Diagnostics, Inc. (AXDXQ : OTC)
 
 • Company Description   
Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado.

Number of Employees: 107

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.01 Daily Weekly Monthly
20 Day Moving Average: 79,773 shares
Shares Outstanding: 25.21 (millions)
Market Capitalization: $0.17 (millions)
Beta: -0.15
52 Week High: $0.04
52 Week Low: $0.00
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 23.64% 18.05%
12 Week -98.76% -98.96%
Year To Date -99.43% -99.47%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
3950 South Country Club Road Suite 470
-
Tucson,AZ 85714
USA		 ph: 520-365-3100
fax: 520-269-6580		 investors@axdx.com https://acceleratediagnostics.com
 
 • General Corporate Information   
Officers
Jack Phillips - President and Chief Executive Officer
Hany Massarany - Chairman
David Patience - Chief Financial Officer
Mark Black - Director
Wayne Burris - Director

Peer Information
Accelerate Diagnostics, Inc. (ABMD)
Accelerate Diagnostics, Inc. (DMDS)
Accelerate Diagnostics, Inc. (CPWY.)
Accelerate Diagnostics, Inc. (EQUR)
Accelerate Diagnostics, Inc. (ECIA)
Accelerate Diagnostics, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 00430H201
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/24
Next Expected EPS Date: 08/14/25
Share - Related Items
Shares Outstanding: 25.21
Most Recent Split Date: 7.00 (0.10:1)
Beta: -0.15
Market Capitalization: $0.17 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/14/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 0.01
EPS Growth
vs. Year Ago Period: 58.43%
vs. Previous Quarter: 37.29%
Sales Growth
vs. Year Ago Period: -6.97%
vs. Previous Quarter: -5.34%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -
12/31/24 - -184.45
Current Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - 0.71
Quick Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - 0.62
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -451.20
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -451.20
Pre-Tax Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -428.37
Book Value
06/30/25 - -
03/31/25 - -
12/31/24 - -2.24
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - 2.92
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - -
 

Powered by Zacks Investment Research ©